Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Acute Ischemic Stroke Patients With Recent DOAC Ingestion
NCT07621796Phase 3Not yet recruiting
- Sponsor
- Hackensack Meridian Health
- Start
- Jan 2027
- Primary completion
- Jan 2032
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Hackensack Meridian Health. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07621796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07621796.